NUMENOS is committed to improving patient outcomes and reducing suffering through the use of AI and modern technologies. Our CURE platform integrates & analyzes clinical trial data, revealing valuable insights that guide decision-making and patient stratification. We aim to unlock new possibilities in drug development and enhance the efficiency of clinical trials. With a diverse team of entrepreneurs, biologists, physicists, and AI specialists, we leverage our expertise to address the challenges faced in the pharmaceutical industry, aiming for higher trial significance and successful drug differentiation.